Kwality Pharmaceuticals reports unaudited Q2 2025 financial results

Kwality Pharmaceuticals Limited announced the publication of its unaudited financial results for the quarter and half year ended September 30, 2025. The results were published in the Financial Express (English) and Punjabi Jagran (Punjabi) on November 15, 2025.

The announcement details the company's standalone and consolidated performance for the specified period. Further financial specifics, such as revenue, net profit, and earnings per share, are contained within the published newspaper excerpts, available for review by interested parties.

This disclosure serves to inform shareholders and the wider market about the company's recent financial performance. The filing was submitted by ramesh arora, managing director.